VALIDOGEN GmbH is an Austrian contract research and development organization specializing in recombinant protein expression using Pichia pastoris. Through its proprietary UNLOCK PICHIA? technology, VALIDOGEN provides customized solutions for methanol-induced and methanol-free protein production, supporting customers from early feasibility and lead identification through strain development, process optimization, scale-up, and technology transfer toward commercial manufacturing.